Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPB for Open Renal Surgery
NCT04118101Phase 3Completed
- Sponsor
- Theodor Bilharz Research Institute
- Start
- Oct 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Theodor Bilharz Research Institute. Primary endpoint: Time to first rescue analgesia. Started Oct 2019; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04118101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04118101.